Milestone reflects the company’s continued impact in providing global pharmaceutical
Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”) today announced
Maple Grove, Minnesota, December 1, 2025 – Bora Pharmaceuticals Co.,
MISSISSAUGA (October, 2025) — Bora Pharmaceuticals Co., Ltd. (“Bora” or
Leading CDMO selected amongst hundreds of worldwide nominations by Biotech
Isolator line provides U.S.-based fill/finish capacity for partners in oncology
Early 2026 launch of liquid-filled hard capsule capabilities will expand
Buildout includes Gerteis Macro-Pactor® install, with additional investments to follow,
Maple Grove, MN & Taipei, Taiwan – July 23, 2025
Cutting-Edge Technology to Accelerate High-Volume Production; Mississauga Site to be
Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472),
Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472),
